Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers

by Yuji Eso, Hiroshi Seno
Published 2020-08-01

Recent Advances in Immunotherapy for Hepatocellular Carcinoma

by Shigeharu Nakano, Yuji Eso, Hirokazu Okada, Atsushi Takai, Ken Takahashi, Hiroshi Seno
Published 2020-03-01

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization fo...

by Yuji Eso, Atsushi Takai, Ken Takahashi, Yoshihide Ueda, Kojiro Taura, Hiroyuki Marusawa, Hiroshi Seno
Published 2019-03-01

Author Correction: DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis

by Eriko Iguchi, Atsushi Takai, Haruhiko Takeda, Ken Kumagai, Soichi Arasawa, Yuji Eso, Takahiro Shimizu, Yoshihide Ueda, Hiroyuki Marusawa, Hiroshi Seno
Published 2021-07-01

Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma

by Yuji Eso, Shigeharu Nakano, Masako Mishima, Soichi Arasawa, Eriko Iguchi, Fumiyasu Nakamura, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Kojiro Taura, Hiroshi Seno
Published 2019-12-01